Related Experiment Video

Updated: Jul 16, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

[Intracoronary thrombectomy with the Export Aspiration Catheter before angioplasty in patients with ST-segment

R Cohen1, T Domniez, R Foucher

  • 1Service de cardiologie, centre hospitalier Lagny-Marne-la-Vallée, 31, avenue du Général-Leclerc, 77000 Lagny-sur-Marne, France. remycohen@hotmail.com

Annales De Cardiologie Et D'Angeiologie
|March 9, 2007
PubMed

Insights

Export Aspiration Catheter (EAC) thrombectomy before angioplasty is safe and feasible for ST-segment elevation myocardial infarction (STEMI) patients. This procedure improves coronary blood flow and may reduce complications, warranting further large-scale studies.

Area of Science:

  • Interventional Cardiology
  • Cardiovascular Research
  • Thrombosis Management

Background:

  • Distal embolization of atherothrombotic material during angioplasty for STEMI can impede optimal myocardial reperfusion.
  • Effective management of thrombus burden is crucial for improving outcomes in STEMI patients.

Purpose of the Study:

  • To evaluate the safety and feasibility of using the Export Aspiration Catheter (EAC) for thrombectomy prior to angioplasty in STEMI patients.
  • To assess the impact of EAC thrombectomy on improving angiographic results, specifically coronary blood flow, in STEMI.

Main Methods:

  • A prospective study involving 64 consecutive STEMI patients undergoing thrombectomy with EAC before angioplasty.
  • Successful thrombectomy was defined as an improvement in TIMI flow grade of at least 1.
  • Angiographic outcomes, including TIMI flow grade and occurrence of distal embolization, were meticulously recorded.

Main Results:

  • Successful thrombectomy was achieved in 62.5% of patients, significantly increasing mean TIMI flow grade (0.7 to 1.9, P < 0.0001).
  • TIMI grade 3 flow was more frequent after EAC thrombectomy compared to guidewire use alone (51.5% vs. 9%, P = 0.0062).
  • Distal embolization or no-reflow occurred in 12.5% of patients, with no reported vessel injury from EAC. Ischemic time less than 6 hours predicted successful thrombectomy.

Conclusions:

  • Thrombectomy with EAC prior to angioplasty is a safe and feasible adjunctive therapy for STEMI.
  • The procedure appears to reduce thrombus burden, thereby enhancing coronary flow restoration and myocardial reperfusion.
  • Larger randomized trials are necessary to confirm these findings and evaluate the clinical impact on infarct size and patient outcomes.
Abstract

More Related Videos

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...